Breakthroughs in Human Metapneumovirus Vaccine Development: New Hope for Respiratory Infections
Human Metapneumovirus, a virus causing significant respiratory infections, has eluded vaccine development since its discovery in 2001 due to a challenging F protein structure. Recent scientific progress in stabilizing this protein holds promise for effective vaccines. Researchers aim for a groundbreaking dual vaccine to combat hMPV and RSV, decreasing hospitalizations among vulnerable groups. Yet, the absence of available vaccines highlights ongoing challenges in combating these infections.